We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

A Phase Ib Study of NVX-508 in Sickle Cell Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03013426
Recruitment Status : Withdrawn (NuvOx Pharma suspended the clinical program related to this study.)
First Posted : January 6, 2017
Last Update Posted : July 16, 2018
Noguchi Memorial Institute for Medical Research
Information provided by (Responsible Party):
Amma Owusu-Ansah, MD, University of Pittsburgh

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : December 2018
Estimated Study Completion Date : December 2018